Rawstron A - Search Results

1

Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study.

Feyler S, Rawstron A, Jackson G, Snowden JA, Cocks K, Johnson RJ. Feyler S, et al. Among authors: rawstron a. Br J Haematol. 2007 Nov;139(3):429-33. doi: 10.1111/j.1365-2141.2007.06817.x. Br J Haematol. 2007. PMID: 17910633 Free article. Clinical Trial.

2

Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim).

Johnson RJ, Owen RG, Child JA, Morgan GJ, Barnard DL, Dickinson H, Ricketts S, Rawstron A, Evans P, Woodhead V, Major K, Robinson F, Smith GM. Johnson RJ, et al. Among authors: rawstron a. Br J Haematol. 1996 Jun;93(4):863-8. doi: 10.1046/j.1365-2141.1996.d01-1717.x. Br J Haematol. 1996. PMID: 8703818

3

Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.

Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, Rawstron A, Major K, Woodhead V, Robinson F, Jack A, Morgan GJ. Johnson RJ, et al. Among authors: rawstron a. Bone Marrow Transplant. 1996 May;17(5):723-7. Bone Marrow Transplant. 1996. PMID: 8733688

4

Assessment of IgH PCR strategies in multiple myeloma.

Owen RG, Johnson RJ, Rawstron AC, Evans PA, Jack A, Smith GM, Child JA, Morgan GJ. Owen RG, et al. Among authors: rawstron ac. J Clin Pathol. 1996 Aug;49(8):672-5. doi: 10.1136/jcp.49.8.672. J Clin Pathol. 1996. PMID: 8881921 Free PMC article.

5

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ. Rawstron AC, et al. Br J Haematol. 1997 Apr;97(1):46-55. doi: 10.1046/j.1365-2141.1997.72653.x. Br J Haematol. 1997. PMID: 9136941 Free article.

6

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.

Rawstron AC, Davies FE, Owen RG, English A, Pratt G, Child JA, Jack AS, Morgan GJ. Rawstron AC, et al. Br J Haematol. 1998 Jan;100(1):176-83. doi: 10.1046/j.1365-2141.1998.00525.x. Br J Haematol. 1998. PMID: 9450807 Free article.

7

Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.

Pratt G, Johnson RJ, Rawstron AC, Barnard DL, Morgan GJ, Smith GM. Pratt G, et al. Among authors: rawstron ac. Bone Marrow Transplant. 1998 Mar;21(5):455-60. doi: 10.1038/sj.bmt.1701118. Bone Marrow Transplant. 1998. PMID: 9535037 Clinical Trial.

8

Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.

Johnson RJ, Rawstron AC, Richards S, Morgan GJ, Norfolk DR, Hillmen SO. Johnson RJ, et al. Among authors: rawstron ac. Blood. 1998 Jun 15;91(12):4504-8. Blood. 1998. PMID: 9616145 Free article.

9

Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression.

Rawstron A, Barrans S, Blythe D, Davies F, English A, Pratt G, Child A, Morgan G, Jack A. Rawstron A, et al. Br J Haematol. 1999 Jan;104(1):138-43. doi: 10.1046/j.1365-2141.1999.01134.x. Br J Haematol. 1999. PMID: 10027726 Free article.

10

Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma.

Pratt G, Wiles ME, Rawstron AC, Davies FE, Fenton JA, Proffitt JA, Child JA, Smith GM, Morgan GJ. Pratt G, et al. Among authors: rawstron ac. Hematol Oncol. 1998 Jun;16(2):47-55. doi: 10.1002/(sici)1099-1069(199806)16:2<47::aid-hon622>3.0.co;2-3. Hematol Oncol. 1998. PMID: 10065112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page